Autologous Bone Marrow Transplantation in Patients with Acute Nonlymphocytic Leukemia, Using ex Vivo Marrow Treatment with 4-HydroperoxycyclophosphamideAndrew M. Yeager, John R. Wingard, Herbert Kaizer et al.|New England Journal of Medicine|1986Cited by 441
Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell–Replete Haploidentical Donor Transplantation Using Post-Transplant CyclophosphamideAsad Bashey, Mary Eapen, Rizwan Romee et al.|Journal of Clinical Oncology|2017Cited by 325
Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: a comparative analysis of feasibility and outcome for community donors versus related donorsKai Hübel, Michael Boeckh, Rachel A. Carter et al.|Transfusion|2002Cited by 128
Cytomegalovirus (CMV) Cell-Mediated Immunity and CMV Infection After Allogeneic Hematopoietic Cell Transplantation: The REACT StudyRoy F. Chemaly, Ella Ariza‐Heredia, Lynn El Haddad et al.|Clinical Infectious Diseases|2020Cited by 109
Transplantation of Allogeneic Peripheral Blood Stem Cells Mobilized by Recombinant Human Granulocyte Colony Stimulating FactorWilliam Bensinger, C. Dean Buckner, Reginald A. Clift et al.|Stem Cells|1996Cited by 99